BlackRock Health Sciences Term Trust (NYSE:BMEZ) Trading Up 1% – Still a Buy?

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was up 1% during mid-day trading on Thursday . The company traded as high as $14.52 and last traded at $14.47. Approximately 151,282 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 245,519 shares. The stock had previously closed at $14.32.

BlackRock Health Sciences Term Trust Stock Performance

The business has a 50-day simple moving average of $14.27 and a two-hundred day simple moving average of $14.75.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Hedge funds have recently bought and sold shares of the company. Bank of America Corp DE boosted its holdings in shares of BlackRock Health Sciences Term Trust by 4.1% during the third quarter. Bank of America Corp DE now owns 1,535,091 shares of the company’s stock worth $22,136,000 after purchasing an additional 61,105 shares during the last quarter. Invesco Ltd. lifted its stake in shares of BlackRock Health Sciences Term Trust by 42.7% during the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock worth $13,398,000 after purchasing an additional 278,024 shares in the last quarter. Rivernorth Capital Management LLC lifted its stake in shares of BlackRock Health Sciences Term Trust by 24.8% during the first quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock worth $11,620,000 after purchasing an additional 160,629 shares in the last quarter. Saba Capital Management L.P. acquired a new position in shares of BlackRock Health Sciences Term Trust during the first quarter worth about $10,907,000. Finally, Lazard Asset Management LLC lifted its stake in shares of BlackRock Health Sciences Term Trust by 64.2% during the first quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock worth $8,926,000 after purchasing an additional 243,054 shares in the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.